• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮介入后血液透析通路通畅性的前瞻性评估:Cox比例风险分析。

Prospective assessment of hemodialysis access patency after percutaneous intervention: Cox proportional hazards analysis.

作者信息

Bittl John A, Feldman Robert L

机构信息

Ocala Heart and Vascular Institute, Munroe Regional Medical Center, Ocala, Florida, USA.

出版信息

Catheter Cardiovasc Interv. 2005 Nov;66(3):309-15. doi: 10.1002/ccd.20519.

DOI:10.1002/ccd.20519
PMID:16208692
Abstract

Vascular access failure is the greatest limitation of successful hemodialysis, but the factors associated with long-term patency have not been fully elucidated. Outcomes in a consecutive series of 294 thrombosed or failing accesses [128 fistulas (43.5%) and 166 grafts (56.5%) in 179 patients] were analyzed with life table and multivariable Cox proportional hazards analysis. Initial success was achieved in 275 of 294 accesses (95.6%). The median patency after intervention was 206 days (interquartile range, 79-457 days). Fistulas had longer median patency after intervention than grafts (286 vs. 170 days). Nonthrombosed accesses had longer median patency than thrombosed accesses (238 vs. 136 days), but thrombosed fistulas had similar median patency as thrombosed grafts (140 vs. 136 days). The selective use of stents as a bailout for failed balloon dilatation did not significantly reduce long-term patency (196 days for stented accesses vs. 210 days for unstented accesses). Long-term patency was inversely related to final access pressure, but access patency was not related to the presence of central venous occlusions, graft age, patient age, sex, or diabetes. Catheter-based intervention of thrombosed and failing dialysis accesses significantly prolongs patency and usefulness of dialysis accesses. The expanding use of fistulas, improved detection of early access failure, and selective use of bailout stents should enhance long-term access patency.

摘要

血管通路失败是成功进行血液透析的最大限制因素,但与长期通畅相关的因素尚未完全阐明。对连续294例血栓形成或功能不良的血管通路(179例患者中有128条动静脉内瘘(43.5%)和166条移植物血管通路(56.5%))的结果进行了生存表分析和多变量Cox比例风险分析。294条血管通路中有275条(95.6%)首次干预成功。干预后的中位通畅时间为206天(四分位间距,79 - 457天)。干预后,动静脉内瘘的中位通畅时间比移植物血管通路更长(286天对170天)。未形成血栓的血管通路的中位通畅时间比形成血栓的血管通路更长(238天对136天),但形成血栓的动静脉内瘘与形成血栓的移植物血管通路的中位通畅时间相似(140天对136天)。作为球囊扩张失败后的补救措施而选择性使用支架,并未显著降低长期通畅率(置入支架的血管通路为196天,未置入支架的血管通路为210天)。长期通畅率与最终血管通路压力呈负相关,但血管通路通畅率与中心静脉闭塞的存在、移植物使用时长、患者年龄、性别或糖尿病无关。基于导管的血栓形成和功能不良的透析血管通路干预可显著延长透析血管通路的通畅时间和使用寿命。扩大动静脉内瘘的使用、改善早期血管通路失败的检测以及选择性使用补救支架应可提高长期血管通路通畅率。

相似文献

1
Prospective assessment of hemodialysis access patency after percutaneous intervention: Cox proportional hazards analysis.经皮介入后血液透析通路通畅性的前瞻性评估:Cox比例风险分析。
Catheter Cardiovasc Interv. 2005 Nov;66(3):309-15. doi: 10.1002/ccd.20519.
2
Outcome of the use of stent grafts to salvage failed arteriovenous accesses.使用覆膜支架挽救动静脉内瘘失败的结果。
Ann Vasc Surg. 2010 Jan;24(1):34-8. doi: 10.1016/j.avsg.2009.07.007. Epub 2009 Sep 17.
3
Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.血管紧张素转换酶抑制剂可维持聚四氟乙烯移植物通畅。
Nephrol Dial Transplant. 2007 May;22(5):1390-8. doi: 10.1093/ndt/gfl821. Epub 2007 Jan 31.
4
Predictors of early dialysis vascular-access failure after thrombolysis.溶栓后早期透析血管通路失败的预测因素
Am J Nephrol. 2008;28(2):181-9. doi: 10.1159/000110086. Epub 2007 Oct 24.
5
Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.血管紧张素受体阻滞剂和抗血小板药物与动静脉血液透析通路放置后的原发性通畅率改善相关。
J Vasc Surg. 2011 Dec;54(6):1706-12. doi: 10.1016/j.jvs.2011.06.028. Epub 2011 Aug 15.
6
Percutaneous therapy to maintain dialysis access successfully prolongs functional duration after primary failure.经皮治疗以维持透析通路可成功延长初次失败后的功能持续时间。
Ann Vasc Surg. 2007 Jul;21(4):474-80. doi: 10.1016/j.avsg.2007.01.014. Epub 2007 May 14.
7
Endovascular revascularization of chronically thrombosed arteriovenous fistulas and grafts for hemodialysis: a retrospective study in 15 patients with 18 access sites.经腔内血运重建治疗慢性血栓形成的动静脉瘘和血液透析移植物:15 例 18 个血管通路的回顾性研究。
Cardiovasc Intervent Radiol. 2011 Apr;34(2):319-30. doi: 10.1007/s00270-010-9926-7. Epub 2010 Jun 29.
8
Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).血管通路失败与特定药物使用之间的关联:透析结果与实践模式研究(DOPPS)
Am J Kidney Dis. 2002 Dec;40(6):1255-63. doi: 10.1053/ajkd.2002.36895.
9
Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access.用于维持性血液透析通路的上臂动静脉内瘘的治疗效果。
Arch Surg. 2004 Feb;139(2):201-8. doi: 10.1001/archsurg.139.2.201.
10
Outcomes of thrombectomy procedures performed in hemodialysis grafts with early failure.早期失败的血液透析移植物中进行血栓切除术的结果。
J Vasc Interv Radiol. 2011 Mar;22(3):317-24. doi: 10.1016/j.jvir.2010.11.021.

引用本文的文献

1
Treatment of failing arterio-venous dialysis graft by angioplasty, stent, and stent graft: Two-years analysis of patency rates and cost-effectiveness.血管成形术、支架及覆膜支架治疗动静脉透析移植物功能衰竭:通畅率及成本效益的两年分析
Exp Ther Med. 2019 Nov;18(5):4144-4150. doi: 10.3892/etm.2019.8050. Epub 2019 Sep 25.